Animal funds

Phibro Animal Health (NASDAQ:PAHC) versus InterCure (NASDAQ:INCR) Financial Contrast


Inter Cure (NASDAQ:INCRGet a rating) and Phobro Animal Health (NASDAQ: PAHCGet a rating) are both small-cap medical companies, but which stock is better? We’ll compare the two companies based on earnings strength, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk.

Benefits and evaluation

This table compares the revenue, earnings per share and valuation of InterCure and Phibro Animal Health.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
InterCure $68.00 million 3.87 $1.45 million $0.12 51.33
Phibro Animal Health $833.40 million 0.87 $54.38 million $1.45 12.34

Phibro Animal Health has higher revenues and profits than InterCure. Phibro Animal Health trades at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares the net margins, return on equity and return on assets of InterCure and Phibro Animal Health.

Net margins Return on equity return on assets
InterCure 5.38% 3.23% 2.22%
Phibro Animal Health 6.48% 21.06% 5.98%

Institutional and Insider Ownership

9.3% of InterCure’s shares are held by institutional investors. By comparison, 50.1% of Phibro Animal Health’s shares are held by institutional investors. 50.1% of the shares of Phibro Animal Health are held by insiders of the company. Strong institutional ownership indicates that hedge funds, endowments, and large fund managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommendations for InterCure and Phibro Animal Health, provided by MarketBeat.com.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
InterCure 0 0 0 0 N / A
Phibro Animal Health 0 2 0 0 2.00

Phibro Animal Health has a consensus target price of $23.00, which suggests a potential upside of 28.56%. Given the higher possible upside of Phibro Animal Health, analysts clearly believe that Phibro Animal Health is more favorable than InterCure.

Summary

Phibro Animal Health beats InterCure on 9 out of 11 factors compared between the two stocks.

About InterCure (Get a rating)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing and distribution of medical cannabis products in Israel and abroad. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in the biomedical sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

About Phibro Animal Health (Get a rating)

Phibro Animal Health Corporation develops, manufactures and supplies a line of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition and Performance Products. The company develops, manufactures and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also include antibacterials which are biological or chemical products used in the animal health industry to treat or prevent bacterial diseases; anticoccidials mainly used to prevent and control coccidiosis in poultry and livestock; anthelmintics to treat parasitic intestinal worm infestations; and anti-bloat treatment products for livestock to control bloat in animals that graze on legume or wheat pastures. In addition, the company offers specialty nutritional products, which enhance nutrition to help improve health and performance; and vaccines to prevent disease primarily for the poultry and pork markets. In addition, it manufactures and markets formulations and concentrations of trace elements, such as zinc, manganese, copper, iron and other compounds; and various specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries. The Company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine and cattle integrators, as well as through commercial manufacturers, wholesalers and distributors of ‘Food for animals. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa and Asia-Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.



Get news and reviews for InterCure Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for InterCure and related companies with MarketBeat.com’s FREE daily email newsletter.